ABBOTINDIA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Abbott India has submitted to BSE the newspaper cuttings of its unaudited financial results for the quarter and half year ended September 30, 2025, published in Business Standard (All Editions) and Loksatta (Mumbai) on November 7, 2025, as required under SEBI LODR Regulation 47. For Q2 FY26, total income from operations stood at ₹1,827.10 crore, up about 7.9% from ₹1,693.15 crore in Q2 FY25. Net profit after tax rose to ₹415.27 crore from ₹358.61 crore, a growth of roughly 15.8% year-on-year. For the half year ended September 30, 2025, total income was ₹3,638.29 crore versus ₹3,318.09 crore last year, while net profit after tax came in at ₹781.13 crore compared to ₹686.62 crore, up about 13.8%. Basic and diluted EPS for the quarter was ₹195.42 (vs ₹168.76) and for the half year ₹367.59 (vs ₹323.12).
This is a routine procedural filing (newspaper republication of results already disclosed to the exchange), not new information. However, the underlying numbers show healthy mid-teens profit growth and stable margins, which is a positive signal for existing shareholders and reinforces Abbott India's track record of consistent earnings expansion.